JP2021513999A5 - - Google Patents
Info
- Publication number
- JP2021513999A5 JP2021513999A5 JP2020544445A JP2020544445A JP2021513999A5 JP 2021513999 A5 JP2021513999 A5 JP 2021513999A5 JP 2020544445 A JP2020544445 A JP 2020544445A JP 2020544445 A JP2020544445 A JP 2020544445A JP 2021513999 A5 JP2021513999 A5 JP 2021513999A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- dose
- composition according
- itrs
- adjacent
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023207938A JP2024028931A (ja) | 2018-02-22 | 2023-12-08 | 閉端ｄｎａ（ｃｅｄｎａ）ベクターを使用した導入遺伝子の制御された発現 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862633757P | 2018-02-22 | 2018-02-22 | |
| US201862633795P | 2018-02-22 | 2018-02-22 | |
| US201862633882P | 2018-02-22 | 2018-02-22 | |
| US62/633,882 | 2018-02-22 | ||
| US62/633,795 | 2018-02-22 | ||
| US62/633,757 | 2018-02-22 | ||
| US201862746762P | 2018-10-17 | 2018-10-17 | |
| US62/746,762 | 2018-10-17 | ||
| PCT/US2019/018927 WO2019165050A1 (en) | 2018-02-22 | 2019-02-21 | Controlled expression of transgenes using close-ended dna (cedna) vectors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023207938A Division JP2024028931A (ja) | 2018-02-22 | 2023-12-08 | 閉端ｄｎａ（ｃｅｄｎａ）ベクターを使用した導入遺伝子の制御された発現 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021513999A JP2021513999A (ja) | 2021-06-03 |
| JP2021513999A5 true JP2021513999A5 (https=) | 2022-03-01 |
| JPWO2019165050A5 JPWO2019165050A5 (https=) | 2022-03-01 |
Family
ID=67687406
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544445A Pending JP2021513999A (ja) | 2018-02-22 | 2019-02-21 | 閉端ｄｎａ（ｃｅｄｎａ）ベクターを使用した導入遺伝子の制御された発現 |
| JP2023207938A Pending JP2024028931A (ja) | 2018-02-22 | 2023-12-08 | 閉端ｄｎａ（ｃｅｄｎａ）ベクターを使用した導入遺伝子の制御された発現 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023207938A Pending JP2024028931A (ja) | 2018-02-22 | 2023-12-08 | 閉端ｄｎａ（ｃｅｄｎａ）ベクターを使用した導入遺伝子の制御された発現 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220175970A1 (https=) |
| EP (1) | EP3755803A4 (https=) |
| JP (2) | JP2021513999A (https=) |
| KR (1) | KR20200124250A (https=) |
| CN (1) | CN111886343A (https=) |
| AU (1) | AU2019225937A1 (https=) |
| BR (1) | BR112020017060A2 (https=) |
| CA (1) | CA3092059A1 (https=) |
| IL (1) | IL276658A (https=) |
| MA (1) | MA51915A (https=) |
| MX (1) | MX2020008676A (https=) |
| PH (1) | PH12020551235A1 (https=) |
| SG (1) | SG11202007621TA (https=) |
| WO (1) | WO2019165050A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202545984A (zh) | 2017-08-09 | 2025-12-01 | 美商生物化學醫療公司 | 核酸分子及其用途 |
| WO2020033863A1 (en) | 2018-08-09 | 2020-02-13 | Bioverativ Therapeutics Inc. | Nucleic acid molecules and uses thereof for non-viral gene therapy |
| CN113316640A (zh) * | 2018-11-09 | 2021-08-27 | 世代生物公司 | 包含对称的被修饰的反向末端重复序列的被修饰的封闭端dna(cedna) |
| DE102020111571A1 (de) | 2020-03-11 | 2021-09-16 | Immatics US, Inc. | Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren |
| AU2021244559A1 (en) * | 2020-03-24 | 2022-11-17 | Generation Bio Co. | Non-viral DNA vectors and uses thereof for expressing Gaucher therapeutics |
| MX2022011805A (es) * | 2020-03-24 | 2023-01-11 | Generation Bio Co | Vectores de adn no virales y usos de estos para expresar agentes terapéuticos con factor ix. |
| JP2023524010A (ja) * | 2020-04-28 | 2023-06-08 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 高効率遺伝子送達系 |
| US20230265440A1 (en) * | 2020-06-26 | 2023-08-24 | The Board Of Trustees Of The Leland Stanford Junior University | Targeting the human ccr5 locus as a safe harbor for the expression of therapeutic proteins |
| CN116234917A (zh) | 2020-07-27 | 2023-06-06 | 安杰瑞姆生物科学公司 | Dna分子组合物及其制备方法和使用方法 |
| US20220090130A1 (en) * | 2020-08-23 | 2022-03-24 | Bioverativ Therapeutics Inc. | MODIFIED BACULOVIRUS SYSTEM FOR IMPROVED PRODUCTION OF CLOSED-ENDED DNA (ceDNA) |
| US20240026374A1 (en) * | 2020-09-16 | 2024-01-25 | Generation Bio Co. | Closed-ended dna vectors and uses thereof for expressing phenylalanine hydroxylase (pah) |
| CA3211687A1 (en) * | 2021-03-19 | 2022-09-22 | Ozan ALKAN | Non-viral dna vectors and uses thereof for expressing pfic therapeutics |
| WO2025114932A1 (en) * | 2023-11-30 | 2025-06-05 | Sanofi | Purification of closed-ended dna molecules |
| CN121662213B (zh) * | 2026-02-06 | 2026-04-21 | 湖南博极生命科技有限公司 | 基于注意力权重追溯的中药活性成分可解释性分析方法及系统 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003087334A2 (en) * | 2002-04-09 | 2003-10-23 | Cornell Research Foundation, Inc. | Use of aav integration efficiency element for mediating site-specific integration of a transcription unit |
| LT2816118T (lt) * | 2005-05-31 | 2018-12-10 | The Regents Of The University Of Colorado, A Body Corporate | Genų pristatymo būdai |
| JP2010538675A (ja) * | 2007-09-19 | 2010-12-16 | アムステルダム モレキュラー セラピューティクス ビー．ブイ． | タンパク質産生の改善のためのａａｖ複製機構の使用 |
| EP2500434A1 (en) * | 2011-03-12 | 2012-09-19 | Association Institut de Myologie | Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery |
| WO2015191508A1 (en) * | 2014-06-09 | 2015-12-17 | Voyager Therapeutics, Inc. | Chimeric capsids |
| AU2015311704B2 (en) * | 2014-09-07 | 2021-12-09 | Selecta Biosciences, Inc. | Methods and compositions for attenuating gene editing anti-viral transfer vector immune responses |
| EP3889260A1 (en) * | 2014-12-12 | 2021-10-06 | The Broad Institute, Inc. | Protected guide rnas (pgrnas) |
| WO2017152149A1 (en) * | 2016-03-03 | 2017-09-08 | University Of Massachusetts | Closed-ended linear duplex dna for non-viral gene transfer |
-
2019
- 2019-02-21 MA MA051915A patent/MA51915A/fr unknown
- 2019-02-21 BR BR112020017060-7A patent/BR112020017060A2/pt not_active Application Discontinuation
- 2019-02-21 PH PH1/2020/551235A patent/PH12020551235A1/en unknown
- 2019-02-21 MX MX2020008676A patent/MX2020008676A/es unknown
- 2019-02-21 AU AU2019225937A patent/AU2019225937A1/en not_active Abandoned
- 2019-02-21 SG SG11202007621TA patent/SG11202007621TA/en unknown
- 2019-02-21 WO PCT/US2019/018927 patent/WO2019165050A1/en not_active Ceased
- 2019-02-21 KR KR1020207026566A patent/KR20200124250A/ko not_active Ceased
- 2019-02-21 US US16/971,016 patent/US20220175970A1/en active Pending
- 2019-02-21 CA CA3092059A patent/CA3092059A1/en active Pending
- 2019-02-21 EP EP19757005.4A patent/EP3755803A4/en active Pending
- 2019-02-21 CN CN201980019861.5A patent/CN111886343A/zh active Pending
- 2019-02-21 JP JP2020544445A patent/JP2021513999A/ja active Pending
-
2020
- 2020-08-11 IL IL276658A patent/IL276658A/en unknown
-
2023
- 2023-12-08 JP JP2023207938A patent/JP2024028931A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021513999A5 (https=) | ||
| Wagner et al. | Synthetic biology: emerging concepts to design and advance adeno‐associated viral vectors for gene therapy | |
| EP2675484B1 (en) | Improved aav8 vector with enhanced functional activity and methods of use thereof | |
| JP2020532981A5 (https=) | ||
| JP2020528734A5 (https=) | ||
| IL299325B2 (en) | Acid-alpha glucosidase variants and uses thereof | |
| RU2018119710A (ru) | Кодирующие фактор viii варианты с пониженным содержанием cpg, композиции и способы, и применение в лечении нарушений гемостаза | |
| FI3684423T3 (fi) | Adenoassesioidun viruksen kapsidivariantteja ja niiden käyttömenetelmiä | |
| US20190292250A1 (en) | Aav-anti-vegf for treating cancer in companion animals | |
| JP2021513355A5 (https=) | ||
| JP2017529395A5 (https=) | ||
| JPWO2019165050A5 (https=) | ||
| JP2020519284A5 (https=) | ||
| JPWO2019161059A5 (https=) | ||
| CN121925426A (zh) | 肝脏去靶向衣壳 | |
| CN120787264A (zh) | 肝脏去靶向衣壳 | |
| JP2021511020A5 (https=) | ||
| JPWO2020159970A5 (https=) | ||
| JPWO2020186207A5 (https=) | ||
| JPWO2020186150A5 (https=) | ||
| JP2025515356A5 (https=) | ||
| RU2020118342A (ru) | Оптимизированные гены aga и экспрессионные кластеры и их применение | |
| JPWO2020237130A5 (https=) | ||
| RU2020131041A (ru) | КОНТРОЛИРУЕМАЯ ЭКСПРЕССИЯ ТРАНСГЕНОВ С ИСПОЛЬЗОВАНИЕМ ДНК-ВЕКТОРОВ С ЗАМКНУТЫМИ КОНЦАМИ (зкДНК) | |
| JPWO2021195218A5 (https=) |